Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

NCT00266630 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
139
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eli Lilly and Company